Conversation about the global rise of obesity and its association with diabetes and the limited effectiveness of many pharmacotherapies tested for management of obesity. You will also learn about weight loss benefits, improvement in cardiovascular risk factors, and potential for cardiovascular event reduction with GLP-1RA therapy in patients with obesity. Claim CE Credit at <a href= "https://bit.ly/3OkYJm9">https://bit.ly/3OkYJm9</a>

Conversation about the global rise of obesity and its association with diabetes and the limited effectiveness of many pharmacotherapies tested for management of obesity. You will also learn about weight loss benefits, improvement in cardiovascular risk factors, and potential for cardiovascular event reduction with GLP-1RA therapy in patients with obesity. Claim CE Credit at https://bit.ly/3OkYJm9

Conversation about the global rise of obesity and its association with diabetes and the limited effectiveness of many pharmacotherapies tested for management of obesity. You will also learn about weight loss benefits, improvement in cardiovascular risk factors, and potential for cardiovascular event reduction with GLP-1RA therapy in patients with obesity. Claim CE Credit at <a href="https://bit.ly/3OkYJm9" rel="noopener noreferrer">https://bit.ly/3OkYJm9</a>

Obesity and GLP-1 RAs

HeartBEATS from Lifelong Learning™ is a series curated by the AHA. Tune in as experts explore highlights on the most up-to-date information to inform your clinical practice.

Share Obesity and GLP-1 RAs

Sign up to save your podcasts

Obesity and GLP-1 RAs

Obesity and GLP-1 RAs

More shows like HeartBEATS from Lifelong Learning™

Invite Health Podcast